2019 - 2023年乌克兰哈尔科夫耐多药结核病中的氟喹诺酮耐药性
Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023.
作者信息
Konstantynovska Olha, Synenko Tetiana, Honcharenko Alla, Volobuieva Olha, Liadova Tetiana, Reimann Maja, Lange Christoph, Chesov Dumitru
出版信息
Emerg Infect Dis. 2025 Mar;31(3):615-617. doi: 10.3201/eid3103.241675.
Abstract
Rifampin-resistant Mycobacterium tuberculosis was identified by the World Health Organization as a pathogen of public health critical importance. During 2014-2023, an increase in fluoroquinolone resistance in rifampin-resistant M. tuberculosis from Kharkiv, Ukraine, was observed. Efforts to mitigate factors contributing to resistance should be prioritized to prevent further escalation of that threat.
摘要
耐利福平结核分枝杆菌被世界卫生组织确定为具有重大公共卫生意义的病原体。在2014年至2023年期间，观察到乌克兰哈尔科夫耐利福平结核分枝杆菌对氟喹诺酮类药物的耐药性有所增加。应优先努力减轻导致耐药性的因素，以防止这一威胁进一步升级。
相似文献
1
Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023.2019 - 2023年乌克兰哈尔科夫耐多药结核病中的氟喹诺酮耐药性
Emerg Infect Dis. 2025 Mar;31(3):615-617. doi: 10.3201/eid3103.241675.
2
Fluoroquinolone-resistant Mycobacterium tuberculosis, Pakistan, 2005-2009.2005 - 2009年，巴基斯坦耐氟喹诺酮结核分枝杆菌
Emerg Infect Dis. 2011 Mar;17(3):564-6. doi: 10.3201/eid1703.100957.
3
Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study.耐药性肺结核中氟喹诺酮类耐药的风险评估与传播：一项回顾性基因组流行病学研究。
Sci Rep. 2024 Aug 24;14(1):19719. doi: 10.1038/s41598-024-70535-y.
4
Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.2005 - 2010年台湾某医疗中心的耐氟喹诺酮类结核病
J Antimicrob Chemother. 2011 Oct;66(10):2437-8. doi: 10.1093/jac/dkr302. Epub 2011 Jul 27.
5
Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola.安哥拉罗安达一家社区医院的耐多药结核分枝杆菌
Emerg Infect Dis. 2025 Mar;31(3):627-629. doi: 10.3201/eid3103.241831.
6
Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.伊朗东北部结核分枝杆菌对氟喹诺酮类药物耐药的基因型和表型特征。
BMC Infect Dis. 2020 Jun 1;20(1):390. doi: 10.1186/s12879-020-05112-5.
7
Fluoroquinolones resistance in multidrug-resistant tuberculosis in Pakistan and suitability of guidelines recommended standardized regimen.巴基斯坦耐多药结核病中氟喹诺酮类药物耐药情况及指南推荐标准化治疗方案的适用性
Int J Mycobacteriol. 2015 Sep;4(3):258-9. doi: 10.1016/j.ijmyco.2015.05.012. Epub 2015 Jun 21.
8
Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis.氟喹诺酮类药物与利福平联合用于异质性耐药结核病的治疗。
Antimicrob Agents Chemother. 2025 Feb 13;69(2):e0108424. doi: 10.1128/aac.01084-24. Epub 2025 Jan 16.
9
Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge.基于微阵列的快速检测结核分枝杆菌利福平、异烟肼和氟喹诺酮耐药性的单一试剂盒。
J Clin Microbiol. 2018 Jan 24;56(2). doi: 10.1128/JCM.01249-17. Print 2018 Feb.
10
Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.安哥拉农村地区结核分枝杆菌复合群耐药情况。
Emerg Infect Dis. 2018 Mar;24(3):569-572. doi: 10.3201/eid2403.171562.
本文引用的文献
1
Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis.全球成人广泛耐药结核病的治疗结局：系统评价和荟萃分析。
J Infect. 2023 Sep;87(3):177-189. doi: 10.1016/j.jinf.2023.06.014. Epub 2023 Jun 23.
2
Emergence of bedaquiline resistance in a high tuberculosis burden country.在结核病负担较高的国家出现了贝达喹啉耐药性。
Eur Respir J. 2022 Mar 24;59(3). doi: 10.1183/13993003.00621-2021. Print 2022 Mar.
3
Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine.乌克兰哈尔科夫地区耐多药结核病。
Int J Tuberc Lung Dis. 2020 May 1;24(5):485-491. doi: 10.5588/ijtld.19.0508.
4
Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients.结核病诊断前氟喹诺酮类药物暴露对免疫功能低下患者临床结局的影响
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4005-12. doi: 10.1128/AAC.01749-15. Print 2016 Jul.
5
Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe.东欧的抗生素使用情况：与世界卫生组织欧洲区域办事处协调的跨国数据库研究。
Lancet Infect Dis. 2014 May;14(5):381-7. doi: 10.1016/S1473-3099(14)70071-4. Epub 2014 Mar 20.
6
Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.与北京结核病转诊医院氟喹诺酮类耐药结核病相关的危险因素。
Respirology. 2011 Aug;16(6):918-25. doi: 10.1111/j.1440-1843.2011.01990.x.
7
Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis.氟喹诺酮类药物与结核病治疗延迟和耐药相关：系统评价和荟萃分析。
Int J Infect Dis. 2011 Mar;15(3):e211-6. doi: 10.1016/j.ijid.2010.11.008. Epub 2010 Dec 30.
Zotero 插件